Strong Q2 Software Growth Raises Guidance; Margin Questions Remain

What happened

In Q2 2026, Axon's Software & Services revenue grew 36.2% year-over-year, driven by premium add-on adoption, leading management to raise its full-year 2026 revenue growth outlook. This aligns with the strong expansion metrics previously disclosed, including 125% net revenue retention and $14.4B future contracted bookings. The news reinforces Axon's platform expansion story, but it comes amid ongoing tariff-driven gross margin pressure and GAAP operating losses that the latest full-year filing highlighted. While software mix gains should support margins over time, the immediate boost is to top-line visibility, not necessarily to profitability. Investors should watch whether the higher guidance is accompanied by any improvement in adjusted gross margin or operating leverage in subsequent quarters.

Implication

The software strength confirms the core expansion engine remains robust, reducing the likelihood of a near-term revenue deceleration that would trigger a multiple compression. However, the stock is still priced for perfection, and the deep value framework's trim level of $620 remains above the current price, suggesting no margin of safety for new buyers. The higher guidance may push the bull scenario probability up slightly, but it does not address the persistent GAAP operating deleverage, tariff costs, or elevated SBC that are central to the bear case. Investors should wait for concrete evidence that adjusted gross margin stabilizes and operating leverage inflects before adding exposure; otherwise the risk of a sharp drawdown on any miss remains high. Thus, the WAIT rating stands, with preference to accumulate near the attractive entry of $440 if the stock retraces.

Thesis delta

The strength in Software & Services and raised guidance slightly increases confidence in the revenue growth and NRR durability assumptions, nudging the probability-weighted fair value upward from $520 to perhaps $540. However, the core concern about margin pressure and valuation has not changed; the key downgrade trigger (NRR < 115% or tariff-driven gross margin declines) is not addressed by this news. Therefore, the thesis remains a WAIT, with a modestly improved forward return profile but no upgrade until margin stabilization is confirmed.